1 story in the last 7 days
The latest rna-therapies news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks rna-therapies across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
SpliSense raised up to $13 million in funding. The company secured the capital to advance its pipeline of RNA-based therapies. SpliSense focuses on developing treatments for cystic fibrosis and other genetic lung diseases.
Summaries by ByteBrief